ACP launches web-based clinical decision support tool

The American College of Physicians (ACP) launched a web-based clinical decision support tool containing 500 modules that provide guidance and information on a broad range of diseases and conditions.

ACP Smart Medicine, available on desktops, smartphones and tablets, integrates content from Annals of Internal Medicine, ACP JournalWise, and ACP clinical practice guidelines, according to a release. The clinical recommendations in ACP Smart Medicine are rated based on the quality of the underlying evidence, according to ACP.

Overall features include:

  • evidence-based recommendations organized into categories: prevention, screening, diagnosis, therapy, consultation, patient education and follow up
  • semantically tagged content
  • differential diagnosis tables to identify correct diagnoses
  • drug information presented in comparative drug tables
  • clinical content categorized by disease, screening and prevention, complementary/alternative, ethical and legal, procedures and quality measure

"ACP Smart Medicine offers physicians high-quality, easy-to-access clinical information that is rigorously peer-reviewed and continually assessed for currency and accuracy. It is a versatile tool that runs the gamut from providing evidence-based guidance to facilitating CME credit, and is the only clinical decision support tool developed by a physician medical society," said Steven Weinberger, MD, ACP's executive vice president and CEO, in a statement.

ACP Smart Medicine also allows physicians to build continuing education credit. Using the tool, they can select modules from the list of content areas they have reviewed, answer a question and submit for CME credit.

ACP members can receive ACP Smart Medicine for free; non-members can purchase it. More information is here

 

 

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.